Global Lysosomal Storage Disease Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: GD443BE1DED5EN
QYResearch

Abstracts

This report focuses on the global Lysosomal Storage Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lysosomal Storage Disease Treatment development in North America, Europe and Asia-Pacific.

The key players covered in this study

• Takeda
• Pfizer
• Sanofi
• BioMarin
• Merck
• Actelion Pharmaceuticals
• Eli Lilly

Market segment by Type, the product can be split into

• Enzyme Replacement Therapy
• Stem Cell Transplantation
• Substrate Reduction Therapy
• Others

Market segment by Application, split into

• Hospitals
• Clinics
• Stem Transplant Centers
• Research Organizations
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Lysosomal Storage Disease Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Lysosomal Storage Disease Treatment development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Lysosomal Storage Disease Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Lysosomal Storage Disease Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Lysosomal Storage Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Enzyme Replacement Therapy
  1.4.3 Stem Cell Transplantation
  1.4.4 Substrate Reduction Therapy
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Lysosomal Storage Disease Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Stem Transplant Centers
  1.5.5 Research Organizations
  1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Lysosomal Storage Disease Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Lysosomal Storage Disease Treatment Industry
    1.6.1.1 Lysosomal Storage Disease Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Lysosomal Storage Disease Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Lysosomal Storage Disease Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Lysosomal Storage Disease Treatment Market Perspective (2015-2026)
2.2 Lysosomal Storage Disease Treatment Growth Trends by Regions
  2.2.1 Lysosomal Storage Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Lysosomal Storage Disease Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Lysosomal Storage Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Lysosomal Storage Disease Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Lysosomal Storage Disease Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Lysosomal Storage Disease Treatment Players by Market Size
  3.1.1 Global Top Lysosomal Storage Disease Treatment Players by Revenue (2015-2020)
  3.1.2 Global Lysosomal Storage Disease Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Lysosomal Storage Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Lysosomal Storage Disease Treatment Market Concentration Ratio
  3.2.1 Global Lysosomal Storage Disease Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Lysosomal Storage Disease Treatment Revenue in 2019
3.3 Lysosomal Storage Disease Treatment Key Players Head office and Area Served
3.4 Key Players Lysosomal Storage Disease Treatment Product Solution and Service
3.5 Date of Enter into Lysosomal Storage Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Lysosomal Storage Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Lysosomal Storage Disease Treatment Forecasted Market Size by Type (2021-2026)

5 LYSOSOMAL STORAGE DISEASE TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Lysosomal Storage Disease Treatment Market Size by Application (2015-2020)
5.2 Global Lysosomal Storage Disease Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Lysosomal Storage Disease Treatment Market Size (2015-2020)
6.2 Lysosomal Storage Disease Treatment Key Players in North America (2019-2020)
6.3 North America Lysosomal Storage Disease Treatment Market Size by Type (2015-2020)
6.4 North America Lysosomal Storage Disease Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Lysosomal Storage Disease Treatment Market Size (2015-2020)
7.2 Lysosomal Storage Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Lysosomal Storage Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Lysosomal Storage Disease Treatment Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Lysosomal Storage Disease Treatment Market Size (2015-2020)
8.2 Lysosomal Storage Disease Treatment Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Type (2015-2020)
8.4 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 Takeda
  9.1.1 Takeda Company Details
  9.1.2 Takeda Business Overview and Its Total Revenue
  9.1.3 Takeda Lysosomal Storage Disease Treatment Introduction
  9.1.4 Takeda Revenue in Lysosomal Storage Disease Treatment Business (2015-2020))
  9.1.5 Takeda Recent Development
9.2 Pfizer
  9.2.1 Pfizer Company Details
  9.2.2 Pfizer Business Overview and Its Total Revenue
  9.2.3 Pfizer Lysosomal Storage Disease Treatment Introduction
  9.2.4 Pfizer Revenue in Lysosomal Storage Disease Treatment Business (2015-2020)
  9.2.5 Pfizer Recent Development
9.3 Sanofi
  9.3.1 Sanofi Company Details
  9.3.2 Sanofi Business Overview and Its Total Revenue
  9.3.3 Sanofi Lysosomal Storage Disease Treatment Introduction
  9.3.4 Sanofi Revenue in Lysosomal Storage Disease Treatment Business (2015-2020)
  9.3.5 Sanofi Recent Development
9.4 BioMarin
  9.4.1 BioMarin Company Details
  9.4.2 BioMarin Business Overview and Its Total Revenue
  9.4.3 BioMarin Lysosomal Storage Disease Treatment Introduction
  9.4.4 BioMarin Revenue in Lysosomal Storage Disease Treatment Business (2015-2020)
  9.4.5 BioMarin Recent Development
9.5 Merck
  9.5.1 Merck Company Details
  9.5.2 Merck Business Overview and Its Total Revenue
  9.5.3 Merck Lysosomal Storage Disease Treatment Introduction
  9.5.4 Merck Revenue in Lysosomal Storage Disease Treatment Business (2015-2020)
  9.5.5 Merck Recent Development
9.6 Actelion Pharmaceuticals
  9.6.1 Actelion Pharmaceuticals Company Details
  9.6.2 Actelion Pharmaceuticals Business Overview and Its Total Revenue
  9.6.3 Actelion Pharmaceuticals Lysosomal Storage Disease Treatment Introduction
  9.6.4 Actelion Pharmaceuticals Revenue in Lysosomal Storage Disease Treatment Business (2015-2020)
  9.6.5 Actelion Pharmaceuticals Recent Development
9.7 Eli Lilly
  9.7.1 Eli Lilly Company Details
  9.7.2 Eli Lilly Business Overview and Its Total Revenue
  9.7.3 Eli Lilly Lysosomal Storage Disease Treatment Introduction
  9.7.4 Eli Lilly Revenue in Lysosomal Storage Disease Treatment Business (2015-2020)
  9.7.5 Eli Lilly Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Lysosomal Storage Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Lysosomal Storage Disease Treatment Revenue
Table 3. Ranking of Global Top Lysosomal Storage Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Lysosomal Storage Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Enzyme Replacement Therapy
Table 6. Key Players of Stem Cell Transplantation
Table 7. Key Players of Substrate Reduction Therapy
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Lysosomal Storage Disease Treatment Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Lysosomal Storage Disease Treatment Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Lysosomal Storage Disease Treatment Players to Combat Covid-19 Impact
Table 14. Global Lysosomal Storage Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Lysosomal Storage Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Lysosomal Storage Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Lysosomal Storage Disease Treatment Market Share by Regions (2015-2020)
Table 18. Global Lysosomal Storage Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Lysosomal Storage Disease Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Lysosomal Storage Disease Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Lysosomal Storage Disease Treatment Players
Table 25. Global Lysosomal Storage Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Lysosomal Storage Disease Treatment Market Share by Players (2015-2020)
Table 27. Global Top Lysosomal Storage Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lysosomal Storage Disease Treatment as of 2019)
Table 28. Global Lysosomal Storage Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Lysosomal Storage Disease Treatment Product Solution and Service
Table 31. Date of Enter into Lysosomal Storage Disease Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Lysosomal Storage Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Lysosomal Storage Disease Treatment Market Size Share by Type (2015-2020)
Table 35. Global Lysosomal Storage Disease Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Lysosomal Storage Disease Treatment Market Size Share by Application (2015-2020)
Table 37. Global Lysosomal Storage Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Lysosomal Storage Disease Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Lysosomal Storage Disease Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Lysosomal Storage Disease Treatment Market Share (2019-2020)
Table 41. North America Lysosomal Storage Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Lysosomal Storage Disease Treatment Market Share by Type (2015-2020)
Table 43. North America Lysosomal Storage Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Lysosomal Storage Disease Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Lysosomal Storage Disease Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Lysosomal Storage Disease Treatment Market Share (2019-2020)
Table 47. Europe Lysosomal Storage Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Lysosomal Storage Disease Treatment Market Share by Type (2015-2020)
Table 49. Europe Lysosomal Storage Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Lysosomal Storage Disease Treatment Market Share by Application (2015-2020)
Table 51. Asia-Pacific Key Players Lysosomal Storage Disease Treatment Revenue (2019-2020) (Million US$)
Table 52. Asia-Pacific Key Players Lysosomal Storage Disease Treatment Market Share (2019-2020)
Table 53. Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Asia-Pacific Lysosomal Storage Disease Treatment Market Share by Type (2015-2020)
Table 55. Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Asia-Pacific Lysosomal Storage Disease Treatment Market Share by Application (2015-2020)
Table 57. Takeda Company Details
Table 58. Takeda Business Overview
Table 59. Takeda Product
Table 60. Takeda Revenue in Lysosomal Storage Disease Treatment Business (2015-2020) (Million US$)
Table 61. Takeda Recent Development
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Product
Table 65. Pfizer Revenue in Lysosomal Storage Disease Treatment Business (2015-2020) (Million US$)
Table 66. Pfizer Recent Development
Table 67. Sanofi Company Details
Table 68. Sanofi Business Overview
Table 69. Sanofi Product
Table 70. Sanofi Revenue in Lysosomal Storage Disease Treatment Business (2015-2020) (Million US$)
Table 71. Sanofi Recent Development
Table 72. BioMarin Company Details
Table 73. BioMarin Business Overview
Table 74. BioMarin Product
Table 75. BioMarin Revenue in Lysosomal Storage Disease Treatment Business (2015-2020) (Million US$)
Table 76. BioMarin Recent Development
Table 77. Merck Company Details
Table 78. Merck Business Overview
Table 79. Merck Product
Table 80. Merck Revenue in Lysosomal Storage Disease Treatment Business (2015-2020) (Million US$)
Table 81. Merck Recent Development
Table 82. Actelion Pharmaceuticals Company Details
Table 83. Actelion Pharmaceuticals Business Overview
Table 84. Actelion Pharmaceuticals Product
Table 85. Actelion Pharmaceuticals Revenue in Lysosomal Storage Disease Treatment Business (2015-2020) (Million US$)
Table 86. Actelion Pharmaceuticals Recent Development
Table 87. Eli Lilly Company Details
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Product
Table 90. Eli Lilly Revenue in Lysosomal Storage Disease Treatment Business (2015-2020) (Million US$)
Table 91. Eli Lilly Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Lysosomal Storage Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Enzyme Replacement Therapy Features
Figure 3. Stem Cell Transplantation Features
Figure 4. Substrate Reduction Therapy Features
Figure 5. Others Features
Figure 6. Global Lysosomal Storage Disease Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Stem Transplant Centers Case Studies
Figure 10. Research Organizations Case Studies
Figure 11. Others Case Studies
Figure 12. Lysosomal Storage Disease Treatment Report Years Considered
Figure 13. Global Lysosomal Storage Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Lysosomal Storage Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Lysosomal Storage Disease Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Lysosomal Storage Disease Treatment Market Share by Players in 2019
Figure 18. Global Top Lysosomal Storage Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lysosomal Storage Disease Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Lysosomal Storage Disease Treatment Revenue in 2019
Figure 20. North America Lysosomal Storage Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Lysosomal Storage Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Asia-Pacific Lysosomal Storage Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Takeda Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2015-2020)
Figure 25. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Pfizer Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2015-2020)
Figure 27. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Sanofi Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2015-2020)
Figure 29. BioMarin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. BioMarin Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2015-2020)
Figure 31. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Merck Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2015-2020)
Figure 33. Actelion Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Actelion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2015-2020)
Figure 35. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Eli Lilly Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed